Paper41865124
Identifying genetic contributions of 6q21 loci and PPAR pathway to antipsychotic-induced metabolic syndrome: a Sex-Stratified Multi-Omics study.
Zhao G and 13 others. Mol Psychiatry, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Identifying genetic contributions of 6q21 loci and PPAR pathway to antipsychotic-induced metabolic syndrome: a Sex-Stratified Multi-Omics study. Papers, record 41865124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41865124
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Identifying genetic contributions of 6q21 loci and PPAR pathway to antipsychotic-induced metabolic syndrome: a Sex-Stratified Multi-Omics study.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antipsychotic Agents | Major topic |
| Metabolic Syndrome | Major topic |
| Peroxisome Proliferator-Activated Receptors | Major topic |
| Adult | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Genetic Risk Score | |
| Genome-Wide Association Study | |
| Genotype | |
| Multiomics | |
| Polymorphism, Single Nucleotide | |
| Proteomics | |
| Risk Factors | |
| Schizophrenia | |
| Signal Transduction |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82330042, 82441005 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed | ||
| 82501828 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed | ||
| 82301687 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed | ||
| Z221100003522010 | Beijing Municipal Science and Technology Commission | PubMed | ||
| 202506010199 | China Scholarship Council (CSC) | PubMed | ||
| 2024M760141 | China Postdoctoral Science Foundation | PubMed |
Source PubMed
References62
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35066115 | Population median imputation was noninferior to complex approaches for imputing missing values in cardiovascular prediction models in clinical practice. | J Clin Epidemiol | 2022 | https://conductscience.org/library/papers/35066115 | PubMed |
| 2 | 33903148 | Integrative study of diet-induced mouse models of NAFLD identifies PPARα as a sexually dimorphic drug target. | Gut | 2022 | https://conductscience.org/library/papers/33903148 | PubMed |
| 3 | 26470795 | Extensive alterations of the whole-blood transcriptome are associated with body mass index: results of an mRNA profiling study involving two large population-based cohorts. | BMC Med Genomics | 2015 | https://conductscience.org/library/papers/26470795 | PubMed |
| 4 | 33279456 | Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia. | EBioMedicine | 2020 | https://conductscience.org/library/papers/33279456 | PubMed |
| 5 | 39349817 | Multivariate genomic analysis of 5 million people elucidates the genetic architecture of shared components of the metabolic syndrome. | Nat Genet | 2024 | https://conductscience.org/library/papers/39349817 | PubMed |
| 6 | 31009912 | Multitarget PPARγ agonists as innovative modulators of the metabolic syndrome. | Eur J Med Chem | 2019 | https://conductscience.org/library/papers/31009912 | PubMed |
| 7 | 34733637 | Metabolic disturbances associated with antipsychotic drug treatment in patients with schizophrenia: State-of-the-art and future perspectives. | World J Psychiatry | 2021 | https://conductscience.org/library/papers/34733637 | PubMed |
| 8 | 35673448 | Metabolic syndrome and underlying genetic determinants-A systematic review. | J Diabetes Metab Disord | 2022 | https://conductscience.org/library/papers/35673448 | PubMed |
| 9 | 27520904 | Prevalence and determinants of metabolic syndrome in patients with schizophrenia: A systematic review and meta-analysis of Indian studies. | Asian J Psychiatr | 2016 | https://conductscience.org/library/papers/27520904 | PubMed |
| 10 | 27782803 | Co-activator candidate interactions for orphan nuclear receptor NR2E1. | BMC Genomics | 2016 | https://conductscience.org/library/papers/27782803 | PubMed |
| 11 | 27070863 | The statistical properties of gene-set analysis. | Nat Rev Genet | 2016 | https://conductscience.org/library/papers/27070863 | PubMed |
| 12 | 37864676 | Evidence-Based Recommendations for the Pharmacological Treatment of Women with Schizophrenia Spectrum Disorders. | Curr Psychiatry Rep | 2023 | https://conductscience.org/library/papers/37864676 | PubMed |
| 13 | 33210212 | Recent Insights on the Role of PPAR-β/δ in Neuroinflammation and Neurodegeneration, and Its Potential Target for Therapy. | Neuromolecular Med | 2021 | https://conductscience.org/library/papers/33210212 | PubMed |
| 14 | 26854917 | Integrative approaches for large-scale transcriptome-wide association studies. | Nat Genet | 2016 | https://conductscience.org/library/papers/26854917 | PubMed |
| 15 | 37269009 | Prediction of treatment response to antipsychotic drugs for precision medicine approach to schizophrenia: randomized trials and multiomics analysis. | Mil Med Res | 2023 | https://conductscience.org/library/papers/37269009 | PubMed |
| 16 | 20694148 | A genome-wide association study of the metabolic syndrome in Indian Asian men. | PLoS One | 2010 | https://conductscience.org/library/papers/20694148 | PubMed |
| 17 | 25885710 | MAGMA: generalized gene-set analysis of GWAS data. | PLoS Comput Biol | 2015 | https://conductscience.org/library/papers/25885710 | PubMed |
| 18 | 38713452 | Sex Differences Between Female and Male Individuals in Antipsychotic Efficacy and Adverse Effects in the Treatment of Schizophrenia. | CNS Drugs | 2024 | https://conductscience.org/library/papers/38713452 | PubMed |
| 19 | 31555747 | Preclinical and Clinical Sex Differences in Antipsychotic-Induced Metabolic Disturbances: A Narrative Review of Adiposity and Glucose Metabolism. | J Psychiatr Brain Sci | 2019 | https://conductscience.org/library/papers/31555747 | PubMed |
| 20 | 25813674 | The relationship between NR2E1 and subclinical inflammation in newly diagnosed type 2 diabetic patients. | J Diabetes Complications | 2015 | https://conductscience.org/library/papers/25813674 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AFG1L | 246269 | PubTator's text mining | https://conductscience.org/library/genes/246269 | NCBI Gene |
| NR2E1 | 7101 | PubTator's text mining | https://conductscience.org/library/genes/7101 | NCBI Gene |
| PPARA | 5465 | PubTator's text mining | https://conductscience.org/library/genes/5465 | NCBI Gene |
| SNX3 | 8724 | PubTator's text mining | https://conductscience.org/library/genes/8724 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41865124
GET https://conductscience.org/api/papers/v1/41865124/references?page=2